Your Journey Starts Now

Type 2 diabetes (T2D) accounts for up to 95% of diabetes in the US and is a frequent cause of chronic kidney disease (CKD). As many as 40% of patients with T2D develop CKD.1,2 As CKD progresses, the risk of kidney and organ damage increases, which is why early detection is crucial to preventing harmful outcomes.2,3

Take the CKD in T2D journey to learn about the scale of the disease, the 3 major drivers of CKD in T2D, and the often understated role of inflammation and fibrosis in CKD progression.

How to Play

Compete against other physicians to finish all three levels in the shortest amount of time. Earn a spot on the leaderboard by

Reading Content

Earn 1 badge per module

Completing a Question Challenge

Earn 1 kidney per module

References

  1. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020.
  2. Alicic RZ, et al. Clin J Am Soc Nephrol. 2017;12(12):2032–2045.
  3. Afkarian M, et al. J Am Soc Nephrol. 2013;24(2):302–308.

Sponsored by Bayer Corp.
PP-UN-CAR-US-0103-1